The safety profile of ciclesonide in the treatment of persistent asthma
Craig T - There was no clinically relevant effect of CIC treatment on growth in children with mild asthma compared with placebo. The favorable safety profile of CIC may allay patient and physician concern regarding ICS when using this agent. Guideline-recommended use of ICS medications may help optimize treatment outcomes in asthma. [more...]
|
|
|
